Stock Markets

Business

Perspective Therapeutics Surges on Promising Cancer Trial Data, But Valuation Gap Raises Questions

Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.

Feb 2, 2026

Business

Diebold Nixdorf's AI-Powered Self-Service Push: A Turning Point for the Turnaround Story?

As Diebold Nixdorf accelerates its AI-driven self-checkout initiatives, highlighted by a new study on the Australian retail market, investors are weighing whether this technological pivot can solidify its ongoing operational turnaround and justify its current valuation.

Feb 2, 2026

World

Argentina Taps U.S. Treasury for $808 Million in IMF Payment, Reports Say

Argentina has reportedly purchased $808 million in Special Drawing Rights from the U.S. Treasury to cover an upcoming interest payment to the International Monetary Fund, highlighting the nation's ongoing financial pressures.

Feb 2, 2026

Business

Euro's Surge Casts Shadow Over ECB Policy Meeting

The European Central Bank convenes this week with a resurgent euro presenting a fresh dilemma, threatening to dampen inflation and undermine the export engine of the eurozone's largest economies just as recovery gains momentum.

Feb 2, 2026

Business

Oracle Seeks Massive $50 Billion War Chest to Fuel AI Cloud Race, Despite Cash Flow Strain

Oracle Corp. plans a colossal $45-$50 billion capital raise in 2026 to expand its cloud infrastructure, aiming to meet surging demand from AI giants like OpenAI and Nvidia. The move comes as the company's aggressive data center spending pushes its free cash flow negative, a condition projected to last for years.

Feb 2, 2026

Business

Micron's AI-Driven Surge: Can the Memory Chip Giant Sustain Its Momentum?

Micron Technology, a key player in memory chips, is poised for explosive earnings growth fueled by insatiable AI demand. Yet, its cyclical nature and commoditized market pose significant long-term risks for investors.

Feb 2, 2026

Business

Powering the AI Boom: How a Nuclear-Heavy Utility Is Capitalizing on Tech's Energy Crisis

As artificial intelligence drives an unprecedented surge in electricity demand, one utility company—Constellation Energy—is uniquely positioned with its vast nuclear fleet to meet the need, turning an industry-wide bottleneck into a significant growth opportunity.

Feb 2, 2026

Business

Dollar Bears Caught Off Guard as Warsh Fed Chair Rumors Spark Sharp Rebound

Asset managers ramped up bearish bets against the U.S. dollar to their highest level in months, only to be blindsided by a sudden rally fueled by speculation that former Fed Governor Kevin Warsh is President Trump's pick to lead the central bank.

Feb 2, 2026

Business

Nvidia's 2026 Outlook: Can the AI Titan Reclaim Its High-Flying Growth Trajectory?

After a relatively subdued 2025, Wall Street's projections for Nvidia's revenue growth remain robust. Analysts are debating whether the chipmaker's current valuation sets the stage for a significant rebound or a period of consolidation.

Feb 2, 2026

Business

Market Rotation Fuels Resurgence: Three High-Dividend ETFs Poised for 2026

As a significant equity rotation takes hold in early 2026, shifting focus from growth to value, dividend-focused ETFs are emerging as key beneficiaries for investors seeking yield and stability.

Feb 2, 2026

Business

Goldcom's Meteoric Rise: Is the Rally Over, or Just Beginning?

Goldcom's (GOLD) shares have soared nearly 90% in the past year, leaving investors to grapple with a critical question: has the market already priced in all the good news, or is there still room to run? A deep dive into the valuation metrics reveals a stark contradiction.

Feb 2, 2026

Business

Analysts Bullish on Applied Materials as Chip Spending Surge Lifts Equipment Giant

Driven by a global wave of semiconductor investment, Applied Materials (AMAT) has received a series of analyst upgrades. Mizuho and Deutsche Bank are among those highlighting the company's strategic position to benefit from expansive fab construction in the U.S., Taiwan, and Japan, and its key role in next-generation chip technologies.

Feb 2, 2026

Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Feb 2, 2026

Business

From Nvidia to Quantum: The $20 Million Investor's Blueprint for Spotting the Next Tech Megatrend

A software engineer who turned an early bet on Nvidia into a $20 million fortune and early retirement is now pointing to quantum computing as the frontier with similar explosive potential. His journey underscores the high-risk, high-reward nature of thematic investing.

Feb 2, 2026

Business

Boeing's Record $682 Billion Order Backlog Signals Brighter Skies Ahead

While Boeing's Q4 revenue beat offers short-term relief, analysts point to its unprecedented order backlog as the true indicator of long-term recovery and growth potential in the commercial aviation sector.

Feb 2, 2026

Business

KPJ Healthcare Berhad Sees Accelerating Returns on Capital, Signaling Strategic Growth

The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.

Feb 2, 2026

Business

EG Industries Berhad's Capital Efficiency Surge Catches Investor Attention

The Malaysian electronics manufacturing services provider is showing compelling financial momentum, with its return on capital employed significantly outpacing industry averages and signaling potential for sustained growth.

Feb 2, 2026

World

Asahi Poll Predicts Landslide Victory for PM Takaichi's LDP in Upcoming Election

A new poll indicates Prime Minister Sanae Takaichi's ruling coalition is on track for a decisive win in next week's lower house election, potentially strengthening her mandate for expansive fiscal policies.

Feb 2, 2026

Business

Ethos Technologies (LIFE): A Deep Value Trap or a Hidden Gem?

Shares of Ethos Technologies have slumped 10.7% year-to-date, trading around $15.05. A detailed valuation analysis reveals a stark contradiction: while a discounted cash flow model suggests massive undervaluation, its price-to-earnings ratio paints a picture of overvaluation. This divergence highlights the critical debate among investors about the insurer's true worth and future trajectory.

Feb 2, 2026

Business

Glaukos Gains FDA Nod for Repeat iDose TR Implant, Bolstering Its Long-Term Glaucoma Platform Strategy

The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.

Feb 2, 2026